ANA-话题@MedSci

#ANA#

386篇内容 | 2264人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1633294, encodeId=c4d31633294e9, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=序贯Meta分析（sequential meta-analyses ）简要介绍, objectType=article, longId=27384, objectId=96232e38474, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=96232e38474, replyNumber=0, likeNumber=50, createdTime=2014-02-26, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=96232e38474, moduleTitle=序贯Meta分析（sequential meta-analyses ）简要介绍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=96232e38474)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633304, encodeId=f6da1633304d8, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Mersana与默克达成ADC研发协议, objectType=article, longId=37087, objectId=309a3e08777, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=309a3e08777, replyNumber=0, likeNumber=77, createdTime=2015-04-30, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=309a3e08777, moduleTitle=Mersana与默克达成ADC研发协议, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=309a3e08777)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633302, encodeId=90251633302de, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=强生降糖药INVOKANA显著改善老年群体血糖及健康措施, objectType=article, longId=36960, objectId=8f6236960df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f6236960df, replyNumber=0, likeNumber=67, createdTime=2015-01-30, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f6236960df, moduleTitle=强生降糖药INVOKANA显著改善老年群体血糖及健康措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f6236960df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633307, encodeId=4eb7163330e73, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Eur J Anaesthesiol：神经肌肉深阻滞可以改善腹腔镜子宫切除术中的手术条件：一项随机对照试验, objectType=article, longId=37797, objectId=5ed23e79738, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ed23e79738, replyNumber=0, likeNumber=68, createdTime=2014-11-23, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ed23e79738, moduleTitle=Eur J Anaesthesiol：神经肌肉深阻滞可以改善腹腔镜子宫切除术中的手术条件：一项随机对照试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5ed23e79738)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633295, encodeId=a2a016332959a, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=CHMP建议批准强生糖尿病新药VOKANAMET, objectType=article, longId=31075, objectId=1349310e5c7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1349310e5c7, replyNumber=0, likeNumber=56, createdTime=2014-09-28, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1349310e5c7, moduleTitle=CHMP建议批准强生糖尿病新药VOKANAMET, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1349310e5c7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633298, encodeId=e7f216332984f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Br J Anaesth：钟摆再次摆动：晶体or胶体？, objectType=article, longId=33747, objectId=c67533e47dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c67533e47dc, replyNumber=0, likeNumber=55, createdTime=2014-05-06, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c67533e47dc, moduleTitle=Br J Anaesth：钟摆再次摆动：晶体or胶体？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c67533e47dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633303, encodeId=ebf7163330327, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Anal Chem：磁共振成像系统助力酶促成胶过程研究获进展, objectType=article, longId=36989, objectId=00ac3698959, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00ac3698959, replyNumber=0, likeNumber=92, createdTime=2014-08-11, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00ac3698959, moduleTitle=Anal Chem：磁共振成像系统助力酶促成胶过程研究获进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00ac3698959)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633299, encodeId=f2321633299f7, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=强生糖尿病新药VOKANAMET获欧盟批准, objectType=article, longId=34600, objectId=50f53460013, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50f53460013, replyNumber=0, likeNumber=56, createdTime=2014-07-08, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50f53460013, moduleTitle=强生糖尿病新药VOKANAMET获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50f53460013)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633293, encodeId=cd9f16332934b, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=强生糖尿病新药INVOKANA获欧盟批准, objectType=article, longId=27074, objectId=00f42e07433, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=00f42e07433, replyNumber=0, likeNumber=59, createdTime=2014-07-23, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=00f42e07433, moduleTitle=强生糖尿病新药INVOKANA获欧盟批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=00f42e07433)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633290, encodeId=ef32163329089, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Lancet：canagliflozin与格列美脲疗效及安全性, objectType=article, longId=22145, objectId=374e2214553, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=374e2214553, replyNumber=0, likeNumber=79, createdTime=2014-03-06, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=374e2214553, moduleTitle=Lancet：canagliflozin与格列美脲疗效及安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=374e2214553)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633291, encodeId=2aba1633291af, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=ISTH 2013：Khorana评分能用于肿瘤患者死亡风险的评估, objectType=article, longId=22152, objectId=73b7221524b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73b7221524b, replyNumber=0, likeNumber=68, createdTime=2014-04-30, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73b7221524b, moduleTitle=ISTH 2013：Khorana评分能用于肿瘤患者死亡风险的评估, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=73b7221524b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633289, encodeId=1c951633289ab, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Anesth Analg：麻醉科医生抑郁患病率高或影响病人安全, objectType=article, longId=20167, objectId=53ce2016eae, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=53ce2016eae, replyNumber=0, likeNumber=51, createdTime=2014-03-26, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=53ce2016eae, moduleTitle=Anesth Analg：麻醉科医生抑郁患病率高或影响病人安全, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=53ce2016eae)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633292, encodeId=d41e16332926f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件, objectType=article, longId=25622, objectId=074b25622ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=074b25622ce, replyNumber=0, likeNumber=61, createdTime=2014-02-06, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=074b25622ce, moduleTitle=ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=074b25622ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633285, encodeId=f9ed16332857f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=MD Consult：Invokana获准用于2型糖尿病, objectType=article, longId=17146, objectId=74171e146e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74171e146e8, replyNumber=0, likeNumber=64, createdTime=2014-02-27, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74171e146e8, moduleTitle=MD Consult：Invokana获准用于2型糖尿病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74171e146e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633286, encodeId=311e163328615, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Diabetes Care：Canagliflozin降糖效果不劣于西格列汀, objectType=article, longId=17185, objectId=49ad1e185f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49ad1e185f4, replyNumber=0, likeNumber=94, createdTime=2013-09-25, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49ad1e185f4, moduleTitle=Diabetes Care：Canagliflozin降糖效果不劣于西格列汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=49ad1e185f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633287, encodeId=b0bf163328e03, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=NEJM：Canakinumab可有效治疗全身型幼年特发性关节炎, objectType=article, longId=18359, objectId=495b1835965, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=495b1835965, replyNumber=0, likeNumber=95, createdTime=2014-01-29, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=495b1835965, moduleTitle=NEJM：Canakinumab可有效治疗全身型幼年特发性关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=495b1835965)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633288, encodeId=debd16332888f, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=HRS2013：CABANA试验4年内不会完成可能产生阳性结果, objectType=article, longId=18916, objectId=eacc1891685, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eacc1891685, replyNumber=0, likeNumber=55, createdTime=2013-07-24, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eacc1891685, moduleTitle=HRS2013：CABANA试验4年内不会完成可能产生阳性结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eacc1891685)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633284, encodeId=ef4d1633284e7, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Ⅲ期临床试验表明Canagliflozin治疗糖尿病优于西他列汀, objectType=article, longId=10378, objectId=7414103e857, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7414103e857, replyNumber=0, likeNumber=62, createdTime=2013-09-28, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7414103e857, moduleTitle=Ⅲ期临床试验表明Canagliflozin治疗糖尿病优于西他列汀, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7414103e857)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633283, encodeId=4b3d163328365, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存, objectType=article, longId=8529, objectId=971a852982, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=971a852982, replyNumber=0, likeNumber=55, createdTime=2012-09-13, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=971a852982, moduleTitle=阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=971a852982)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1633280, encodeId=83b9163328032, content=<a href='/topic/show?id=377824e1c0' target=_blank style='color:#2F92EE;'>#ANA#</a>, objectTitle=Vivus公司ED药物Avanafil获EMA批准, objectType=article, longId=5399, objectId=fc215399a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc215399a1, replyNumber=0, likeNumber=61, createdTime=2012-07-05, rootId=0, userName=AspirantSuo, userId=434d22047430, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc215399a1, moduleTitle=Vivus公司ED药物Avanafil获EMA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc215399a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ANA

2020-05-29

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

序贯Meta分析（sequential meta-analyses ）简要介绍

2014-02-26

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Mersana与默克达成ADC研发协议

2015-04-30

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

强生降糖药INVOKANA显著改善老年群体血糖及健康措施

2015-01-30

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Eur J Anaesthesiol：神经肌肉深阻滞可以改善腹腔镜子宫切除术中的手术条件：一项随机对照试验

2014-11-23

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

CHMP建议批准强生糖尿病新药VOKANAMET

2014-09-28

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Br J Anaesth：钟摆再次摆动：晶体or胶体？

2014-05-06

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Anal Chem：磁共振成像系统助力酶促成胶过程研究获进展

2014-08-11

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

强生糖尿病新药VOKANAMET获欧盟批准

2014-07-08

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

强生糖尿病新药INVOKANA获欧盟批准

2014-07-23

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Lancet：canagliflozin与格列美脲疗效及安全性

2014-03-06

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

ISTH 2013：Khorana评分能用于肿瘤患者死亡风险的评估

2014-04-30

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Anesth Analg：麻醉科医生抑郁患病率高或影响病人安全

2014-03-26

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

ANA 2013：卒中后的凝血因子VIII水平或可预测复发事件

2014-02-06

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

MD Consult：Invokana获准用于2型糖尿病

2014-02-27

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Diabetes Care：Canagliflozin降糖效果不劣于西格列汀

2013-09-25

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

NEJM：Canakinumab可有效治疗全身型幼年特发性关节炎

2014-01-29

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

HRS2013：CABANA试验4年内不会完成可能产生阳性结果

2013-07-24

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Ⅲ期临床试验表明Canagliflozin治疗糖尿病优于西他列汀

2013-09-28

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

阿斯利康anastrozole + fulvestrant药物组合显著改善激素相关性乳腺癌患者生存

2012-09-13

AspirantSuo (审核中...)

前往app查看评论内容

#ANA#

Vivus公司ED药物Avanafil获EMA批准

2012-07-05

科室
- - 订阅+
  - 更多科室
工具
服务